Additional insightful information has come from the discovery of novel IgM autoantibodies against angiotensin‐converting enzyme‐2 (ACE2), one of the major host receptors for the coronavirus, in patients with severe COVID‐19.29 The gene discussed is CD40LG; the disease is COVID-19.